<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00345553</url>
  </required_header>
  <id_info>
    <org_study_id>BASIC Study - ChiLDReN Network</org_study_id>
    <secondary_id>U01DK103149</secondary_id>
    <secondary_id>U01DK103140</secondary_id>
    <secondary_id>U01DK103135</secondary_id>
    <secondary_id>U01DK084575</secondary_id>
    <secondary_id>U01DK084538</secondary_id>
    <secondary_id>U01DK084536</secondary_id>
    <secondary_id>U01DK062503</secondary_id>
    <secondary_id>U01DK062500</secondary_id>
    <secondary_id>U01DK062497</secondary_id>
    <secondary_id>U01DK062481</secondary_id>
    <secondary_id>U01DK062470</secondary_id>
    <secondary_id>U01DK062466</secondary_id>
    <secondary_id>U01DK062456</secondary_id>
    <secondary_id>U01DK062453</secondary_id>
    <secondary_id>U01DK062452</secondary_id>
    <secondary_id>U01DK062445</secondary_id>
    <secondary_id>U01DK062436</secondary_id>
    <nct_id>NCT00345553</nct_id>
  </id_info>
  <brief_title>Biliary Atresia Study in Infants and Children</brief_title>
  <acronym>BASIC</acronym>
  <official_title>Biliary Atresia Study in Infants and Children (BASIC)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Arbor Research Collaborative for Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Arbor Research Collaborative for Health</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Little is known about the factors that cause biliary atresia nor the factors that influence&#xD;
      disease progression. The purpose of this study is to collect the pertinent clinical&#xD;
      information, genetic material and body fluid samples to enable investigators to address the&#xD;
      following aims: To identify the gene or genes implicated in the etiology of BA; To identify&#xD;
      polymorphisms that may be important in disease progression such as HLA polymorphisms; To&#xD;
      characterize the natural history of the older, non-transplanted child with BA.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Little is known about the factors that cause biliary atresia nor the factors that influence&#xD;
      disease progression. A variety of genetic, autoimmune and environmental influences have been&#xD;
      hypothesized to be important. Most studies to date have focused on the neonate and young&#xD;
      child with BA, yet the older surviving child with BA can provide important information about&#xD;
      genetics, as well as, natural history.&#xD;
&#xD;
      The purpose of this study is to collect the pertinent clinical information, genetic material&#xD;
      and body fluid samples to enable investigators to address the following hypotheses:&#xD;
&#xD;
      Hypothesis 1: A genetic defect is a likely causative factor for BA among children with BA and&#xD;
      multiple congenital anomalies.&#xD;
&#xD;
      Hypothesis 2: Autoimmune factors are likely to contribute to disease progression or&#xD;
      acquisition and can be identified by correlating HLA among children with BA to healthy&#xD;
      controls and by comparison of those who develop early complications including, variceal&#xD;
      bleed, ascites, and growth failure compared to those who do not.&#xD;
&#xD;
      Hypothesis 3a: Sentinel events such as variceal bleeding, ascites and growth failure are&#xD;
      earlier predictors of death or need for liver transplantation than the pediatric end-stage&#xD;
      liver disease score (PELD).&#xD;
&#xD;
      Hypothesis 3b: Health related quality of life will be impaired compared to healthy age&#xD;
      matched children and relate to severity of illness.&#xD;
&#xD;
      Hypothesis 3c: Growth failure as measured by anthropometrics and nutritional supplementation&#xD;
      will be predictive of onset of sentinel events (ascites, variceal bleed, death, and&#xD;
      transplant) in the following 24 months.&#xD;
&#xD;
      This study will be performed by the Childhood Liver Disease Research Network (ChiLDReN), a&#xD;
      National Institute of Diabetes &amp; Digestive and Kidney Diseases (NIDDK) funded network.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2006</start_date>
  <completion_date type="Anticipated">May 2024</completion_date>
  <primary_completion_date type="Anticipated">May 2024</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>To identify the gene or genes implicated in the etiology of BA</measure>
    <time_frame>Specimens for this aim are collected once during study, usually at baseline.</time_frame>
    <description>The genetics of BA may be investigated on two levels. The first is to identify a group of patients whose etiology is a result of a genetic defect and the second is to examine the influence of genetics on disease acquisition.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>To identify polymorphisms that may be important in disease progression such as Human leukocyte antigen (HLA) polymorphisms</measure>
    <time_frame>Specimens for this aim are collected once during study, usually at baseline.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Define the natural history of the older, non-transplanted child with biliary atresia</measure>
    <time_frame>Observational information collected at entrance into study as well as at each yearly follow-up visit.</time_frame>
    <description>Understanding the natural history of a disease is a prerequisite to interpreting disease severity, identifying patterns of illness, identifying early predictors of outcome and understanding the advantages or trade-offs of therapeutic interventions.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">1265</enrollment>
  <condition>Biliary Atresia</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <description>Biliary atresia subjects who have their native liver</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <description>Biliary atresia subjects who have had a liver transplant</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Samples of blood will be collected for research purposes.&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Recruitment will be open to any eligible subject. The method of contacting the study&#xD;
        subjects will conform to local IRB guidelines, but in general: the parents or guardians of&#xD;
        all eligible subjects at each ChiLDReN center, or the subjects themselves if 18 years of&#xD;
        age or older, will be approached to participate. New patients who are not participating in&#xD;
        ChiLDReN study PROBE may be approached for study participation, but will not be eligible&#xD;
        for enrollment until 6 months of age.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Participants need to have a confirmed diagnosis of BA determined by chart review&#xD;
             including review of pertinent diagnostic biopsy reports, radiologic reports and&#xD;
             surgical reports (if surgery was performed).&#xD;
&#xD;
          2. Participants need to be &gt;6 months of age up to and equal to the age of 20&#xD;
             (participants enrolled at 20 years of age will have one visit).&#xD;
&#xD;
          3. Participants either have their native liver or have a confirmed liver transplantation.&#xD;
&#xD;
          4. Parent, guardian or participant (if 18 years of age or older) is willing to provide&#xD;
             informed consent and, when appropriate, the participant is willing to assent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Currently participating in the ChiLDReN study PROBE&#xD;
&#xD;
          2. Inability to confirm original diagnostic evaluation of biliary atresia&#xD;
&#xD;
          3. Inability or unwillingness of family or participant to participate in all scheduled&#xD;
             visits.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Months</minimum_age>
    <maximum_age>20 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vicky Ng, MD</last_name>
    <role>Study Chair</role>
    <affiliation>The Hospital for Sick Children, Toronto, ON, Canada</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ed Doo, MD</last_name>
    <role>Study Director</role>
    <affiliation>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</affiliation>
  </overall_official>
  <overall_official>
    <last_name>John C Magee, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Michigan</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Robert M Merion, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Arbor Research Collaborative for Health - Data Coordinating Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Averell Sherker, MD</last_name>
    <role>Study Director</role>
    <affiliation>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Joanne Lord, LPN,BA,CCRC</last_name>
    <phone>734-369-9965</phone>
    <email>joanne.lord@arborresearch.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Terese A Howell, BS, CCRC</last_name>
    <phone>734-369-9683</phone>
    <email>terri.howell@arborresearch.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Children's Hospital of Los Angeles</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90027</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Catherine Goodhue, CPNP</last_name>
      <phone>323-361-4566</phone>
      <email>cgoodhue@chla.usc.edu</email>
    </contact>
    <investigator>
      <last_name>Kasper Wang, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sonia Michail, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Danny Thomas, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nisreen Soufi, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Rohit Kohil, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of California at San Francisco</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94143</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Children's Hospital Colorado</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matthew Steinbeiss</last_name>
      <phone>720-777-4800</phone>
      <email>matthew.steinbeiss@childrenscolorado.org</email>
    </contact>
    <contact_backup>
      <last_name>Mikaela Kauma</last_name>
      <phone>720-777-1294</phone>
      <email>mikaela.kauma@childrenscolorado.org</email>
    </contact_backup>
    <investigator>
      <last_name>Ronald J Sokol, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Michael Narkewicz, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Cara Mack, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Shikha Sundaram, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Amy Feldman, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dania Brigham, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's Healthcare of Atlanta - Emory University</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeanette McFall</last_name>
      <phone>404-785-0421</phone>
      <email>jeanette.mcfall@choa.org</email>
    </contact>
    <investigator>
      <last_name>Saul Karpen, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nitika Gupta, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Rene Romero, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Miriam Vos, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ann &amp; Robert H. Lurie Children's Hospital of Chicago</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60614</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sue Kelly, RN, BSN</last_name>
      <phone>312-227-3523</phone>
      <email>skelly@luriechildrens.org</email>
    </contact>
    <contact_backup>
      <last_name>Mary Riordan, CCRP</last_name>
      <phone>312-227-4558</phone>
      <email>mriordan@luriechildrens.org</email>
    </contact_backup>
    <investigator>
      <last_name>Estella Alonso, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lee Bass, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Riley Children's Hospital</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cindy Sawyers, BSRT</last_name>
      <phone>317-944-1421</phone>
      <email>clsawyer@iu.edu</email>
    </contact>
    <contact_backup>
      <last_name>Ann Klipsch, RN</last_name>
      <phone>317-274-9605</phone>
      <email>aeye@iu.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Jean Molleston, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Molly Bozic, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Girish Rao, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Johns Hopkins School of Medicine</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21287</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Washington University School of Medicine</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Mount Sinai Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Children's Hospital Medical Center</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45229</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julie Denlinger</last_name>
      <phone>513-636-7818</phone>
      <email>julie.denlinger@cchmc.org</email>
    </contact>
    <investigator>
      <last_name>Jorge Bezerra, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>James Heubi, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alexander Miethke, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Joseph Palermo, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's Hospital of Philadelphia</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jessi Erlichman</last_name>
      <phone>215-590-2525</phone>
      <email>erlichman@email.chop.edu</email>
    </contact>
    <contact_backup>
      <last_name>Iraklis Petrof</last_name>
      <phone>267-426-8613</phone>
      <email>petrofi@email.chop.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Kathy Loomes, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Elizabeth Rand, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>David Piccoli, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UPMC Children's Hospital of Pittsburgh</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15224</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kathryn Bukauskas, RN, CCRC</last_name>
      <phone>412-692-7703</phone>
      <email>kathryn.bukauskas@chp.edu</email>
    </contact>
    <contact_backup>
      <last_name>Adam Kufen, RN, CCRC</last_name>
      <phone>412-692-6558</phone>
      <email>adam.kufen@chp.org</email>
    </contact_backup>
    <investigator>
      <last_name>Robert Squires, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>James Squires, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Patrick Mckiernan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Texas Children's Hospital (Baylor College of Medicine)</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laurel Cavallo</last_name>
      <phone>832-822-1053</phone>
      <email>laurel.cavallo@bcm.edu</email>
    </contact>
    <contact_backup>
      <last_name>Cynthia Tsai</last_name>
      <phone>832-822-3634</phone>
      <email>ct2@bcm.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Paula Hertel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Benjamin Shneider, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Utah</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84113</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ann Rutherford</last_name>
      <phone>801-585-9495</phone>
      <email>ann.rutherford@hsc.utah.edu</email>
    </contact>
    <contact_backup>
      <last_name>Tyler Hall</last_name>
      <phone>801-587-5670</phone>
      <email>tyler.hall@hsc.utah.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Stephen Guthery, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kyle Jensen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Linda Book, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Seattle Children's Hospital</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98105</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melissa Young</last_name>
      <phone>206-987-1037</phone>
      <email>melissa.young@seattlechildrens.org</email>
    </contact>
    <contact_backup>
      <last_name>Kara Cooper</last_name>
      <phone>206-987-4636</phone>
      <email>kara.cooper@seattlechildrens.org</email>
    </contact_backup>
    <investigator>
      <last_name>Simon Horslen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Evelyn Hsu, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Niviann Blondet, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital for Sick Children</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5G 1X8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Deepika Sharma</last_name>
      <phone>416-813-7654</phone>
      <phone_ext>201594</phone_ext>
      <email>Deepika.sharma@sickkids.ca</email>
    </contact>
    <contact_backup>
      <last_name>Claudia Quammie</last_name>
      <phone>416-813-7654</phone>
      <phone_ext>201594</phone_ext>
      <email>claudia.quammie@sickkids.ca</email>
    </contact_backup>
    <investigator>
      <last_name>Vicki Ng, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Binita Kamath, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.childrennetwork.org</url>
    <description>Childhood Liver Disease Research Network (ChiLDReN) website</description>
  </link>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>June 27, 2006</study_first_submitted>
  <study_first_submitted_qc>June 27, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 28, 2006</study_first_posted>
  <last_update_submitted>April 21, 2021</last_update_submitted>
  <last_update_submitted_qc>April 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Biliary Atresia</keyword>
  <keyword>Cholestasis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Biliary Atresia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>The data will be transferred to NIDDK at the end of the study.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

